Cellmat Therapeutics, Appointment of Jin-tae Kim as Inside Director Rejected
[Asia Economy Reporter Lee Jung-yoon] Cellmat Therapeutics announced on the 30th that the appointment of Jin-tae Kim as an inside director was rejected at the extraordinary general meeting of shareholders.
Hot Picks Today
In the End, Fearing a Strike, Samsung Electronics Removes Wafer Pods... Enters 'Emergency Mode'
- No Bacteria Detected in Arisu After 24 Hours of Repeated Drinking from a Tumbler
- "Available Only in Korea": Pokémon Card Prices Surge 2,532% Due to Rarity, Becoming Investment Assets
- Kumho Tire Invests 59.6 Billion Won in Polish Subsidiary
- Pulling Out His Phone for a '360-Degree Selfie' and Giving a Thumbs Up at the Ceiling... "China Is Fascinating" [US-China Summit]
The company stated, "The appointment of the inside director was rejected as the number of opposing shares exceeded the majority of the shares present."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
